IL6 genotypes and colon and rectal cancer.
Inflammation appears to play a key role in the development of colorectal cancer (CRC). In this study we examine factors involved in the regulation of inflammation and risk of CRC. Data from a multi-center case-control study of colon (N = 1579 cases and N = 1977 controls) and rectal (N = 794 cases and N = 1005 controls) cancer were used to evaluate the association between the rs1800795 and rs1800796 IL6 polymorphisms and CRC. We evaluated the joint effects of IL6 single nucleotide polymorphisms and regular use of aspirin/NSAIDs and vitamin D receptor (VDR) genotype. Having a C allele of the rs1800796 IL6 polymorphisms and the GG genotype of the rs1800795 IL6 polymorphisms was associated with a statistically significantly reduced the risk of colon (OR 0.76 95% CI 0.57, 1.00), but not rectal (OR 1.49 95% CI 1.02,2.16) cancer. Both IL6 polymorphisms were associated with significant interaction with current use of aspirin/NSAIDs to alter risk of colon cancer: individuals with a C allele in either polymorphism who were current users of aspirin/NSAIDs had the lowest colon cancer risk. CRC risk also was associated with an interaction between VDR and IL6 genotypes that was modified by current use of aspirin/NSAIDs. This study provides further support for inflammation-related factors in the etiology of CRC. Other studies are needed to explore other genes in this and other inflammation-related pathways.
Slattery
Martha L
ML
School of Medicine, University of Utah, Salt Lake City, UT 84108, USA. mslatter@hrc.utah.edu
Wolff
Roger K
RK
Herrick
Jennifer S
JS
Caan
Bette J
BJ
Potter
John D
JD
D000328:Adult; D000368:Aged; D000483:Alleles; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020641:Polymorphism, Single Nucleotide; D018167:Receptors, Calcitriol / Q000235:genetics; D012004:Rectal Neoplasms / Q000235:genetics*; D012189:Retrospective Studies; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; C508600:IL6 protein, human; D015850:Interleukin-6; D018167:Receptors, Calcitriol; D001241:Aspirin
Cancer Res. 2003 Jul 1;63(13):3560-6
12839942
Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1267-74
11751444
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):744-9
16614118
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):538-45
15066917
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31
16775170
J Pharm Sci. 1968 Dec;57(12):2111-6
5708353
Mini Rev Med Chem. 2005 Aug;5(8):761-78
16101412
J Clin Endocrinol Metab. 1983 Dec;57(6):1308-10
6313738
Int J Cancer. 2003 Feb 20;103(5):642-6
12494472
Cytokine. 2004 Jul 21-Aug 7;27(2-3):58-65
15242694
Mol Endocrinol. 2003 Dec;17(12):2386-92
14500760
Am J Epidemiol. 1994 Dec 1;140(11):1020-8
7985650
J Clin Endocrinol Metab. 2004 Apr;89(4):1885-90
15070960
Cancer Res. 1997 Mar 15;57(6):1098-102
9067278
Cancer. 1964 May;17:657-65
14159812
Mol Cell Endocrinol. 2001 May 25;177(1-2):145-59
11377830
Arch Intern Med. 1999 Jan 25;159(2):161-6
9927099
Clin Chem. 2004 Nov;50(11):2136-40
15364891
Diabetes. 2002 Jul;51(7):2294-300
12086963
Carcinogenesis. 2003 Jun;24(6):1091-5
12807755
Cancer Causes Control. 2001 May;12(4):359-64
11456232
Cancer Causes Control. 2006 Apr;17(3):239-49
16489531
Crit Care Med. 2005 Jan;33(1):89-97; discussion 242-3
15644653
Gut. 1992 Dec;33(12):1660-3
1336758
N Engl J Med. 1971 Jul 1;285(1):17-21
5089367
Adv Prostaglandin Thromboxane Res. 1980;8:1287-9
6769309
FASEB J. 2003 Mar;17(3):509-11
12551842
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):747-55
17416766
Int J Oncol. 1999 Sep;15(3):589-94
10427145
J Am Diet Assoc. 1994 Jul;94(7):761-6
8021418
Int J Cancer. 2002 Mar 1;98(1):84-91
11857390
Epidemiol Rev. 1993;15(2):499-545
8174669
Eur J Cancer. 2006 Apr;42(6):704-7
16513341
Diabetes. 1966 Oct;15(10):730-3
5924835
Diabetes. 1960 Sep-Oct;9:416-8
13707654
Science. 2001 Aug 31;293(5535):1673-7
11533494
Cancer Causes Control. 2002 Nov;13(9):813-23
12462546
Cancer Lett. 2006 Jun 18;237(2):199-206
16019132
Diabetes Care. 1982 Jan-Feb;5(1):64-71
6754304
JAMA. 2004 Feb 4;291(5):585-90
14762037
Ann Intern Med. 2005 Mar 15;142(6):425-32
15767620
Cancer Res. 1997 Jan 1;57(1):75-80
8988044
J Epidemiol. 2005 Jun;15 Suppl 2:S185-9
16127232
Cancer Causes Control. 2001 Sep;12(7):607-14
11552708
Arch Biochem Biophys. 2002 Jun 15;402(2):249-54
12051670
Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277-300
12887108
Cancer Res. 1992 Oct 15;52(20):5575-89
1394181
J Clin Invest. 2002 May;109(10):1321-6
12021247
World J Gastroenterol. 2006 Aug 21;12(31):5037-43
16937502
J Clin Invest. 1998 Oct 1;102(7):1369-76
9769329
Cancer Res. 2006 Feb 15;66(4):2483-7
16489056
Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):869-74
11489753
J Clin Endocrinol Metab. 2003 Jan;88(1):255-9
12519862
J Cell Biochem. 2003 Aug 1;89(5):922-32
12874827
Br J Cancer. 1999 Sep;81(1):62-8
10487613
Mol Endocrinol. 2000 Mar;14(3):401-20
10707958